Results 121 to 130 of about 55,263 (257)
Disability, Subject‐Dependence, and the Bad‐Difference View
Bioethics, Volume 39, Issue 9, Page 802-809, November 2025.ABSTRACT Philosophers have debated on the “mere‐difference” view of disability, according to which disability as such is neutral in terms of well‐being, just like race and gender. It is contrasted with the “bad‐difference” view, which holds that disability is bad for its possessor even in a non‐ableist situation.
Shu Ishida +2 more
wiley +1 more source
Neurology International, 2019 The co-existence of facioscapulohumeral muscle dystrophy (FSHD) and myasthenia gravis (MG) is very rare and few cases have been described in the literature.
Feryal Nauman +2 more
doaj +1 more source
The use of an online support group for neuromuscular disorders: a thematic analysis of message postings [PDF]
, 2017 Purpose: People affected by neuromuscular disorders can experience adverse psychosocial consequences and difficulties accessing information and support. Online support groups provide new opportunities for peer support.
Han HR +6 more
core +2 more sources
Cochlear Function in Facioscapulohumeral Muscular Dystrophy
Otology & Neurotology, 2007 Facioscapulohumeral muscular dystrophy (FSHD) is commonly associated with high-frequency hearing impairment. Our objective was to evaluate a group of normally hearing patients with FSHD using otoacoustic emissions.Prospective, randomized clinical trial.A tertiary University-based referral center in Athens, Greece.The study group consisted of a ...
Balatsouras, D.G. +4 more
openaire +3 more sources
Turkish Journal of Anaesthesiology and ReanimationFacioscapulohumeral muscular dystrophy (FSHD) is a muscular dystrophy that can affect individuals of all age groups. Its prevalence is reported to be 0.4-1 in 10,000 people. Because of the low occurrence of FSHD, anaesthetic management is primarily based
Mete Manici +4 more
doaj +1 more source
Advanced microscopic and histochemical techniques: diagnostic tools in the molecular era of myology
European Journal of Histochemistry, 2009 Over the past two centuries, myology (i.e. the basic and clinical science of muscle and muscle disease) has passed through 3 stages of development: the classical period, the modern stage and the molecular era.
G Meola
doaj +1 more source
Muscle carbonic anhydrase III levels in normal and muscular dystrophia afflicted chickens [PDF]
, 2012 BACKGROUND: The levels and immunohistochemical localization of muscle carbonic anhydrase III (CA-III) in healthy chickens and in muscular dystrophia affected (DA) chickens show that the muscles of diseased animal undergo a progressive increase of enzyme ...
Daisuke Yorifuji +4 more
core +1 more source
Creatine Phosphokinase in Facioscapulohumeral Muscular Dystrophy [PDF]
BMJ, 1971 Study of the serum creatine kinase levels in young patients with facioscapulohumeral muscular dystrophy suggests that enzyme assay may be valuable as a screening procedure for assessing the status of relatives of an affected individual who have no previous clinical history, and that consequently it may be of use in genetic counselling.
openaire +2 more sources
Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy
Open MedicineStatin use can lead to various muscle-related issues, including benign creatine kinase (CK) elevations, myalgias, toxic myopathies, rhabdomyolysis, and immune-mediated necrotizing myositis (IMNM), which primarily affects older males.
Braun Andreas Albert +5 more
doaj +1 more source
A rare case of myasthenia gravis with coexisting muscular dystrophy [PDF]
, 2014 Myasthenia gravis (MG) is an autoimmune disease in which antibodies are directed against postsynaptic membrane of neuromuscular junction, resulting in muscle weakness and fatigability.
Aftab, Sommayya +2 more
core +1 more source